Freeman Hospital; Northern Centre For Cancer Care

Newcastle upon Tyne NE7 7DN

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Myelodysplastic Syndromes

Studies at this site

• A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer — Completed
• A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer — Completed
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed